These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 39055758

  • 21. Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.
    Wesselowski S, Gordon SG, Fries R, Saunders AB, Sykes KT, Vitt J, Boutet B, Häggström J, Kadotani S, Stack J, Barnett BG.
    J Vet Cardiol; 2023 Dec; 50():1-16. PubMed ID: 37913604
    [Abstract] [Full Text] [Related]

  • 22. Inflammation and its association with oxidative stress in dogs with heart failure.
    Nemec Svete A, Verk B, Čebulj-Kadunc N, Salobir J, Rezar V, Domanjko Petrič A.
    BMC Vet Res; 2021 Apr 26; 17(1):176. PubMed ID: 33902566
    [Abstract] [Full Text] [Related]

  • 23. NT-ProBNP and cardiac troponin I in virulent canine babesiosis.
    Lobetti R, Kirberger R, Keller N, Kettner F, Dvir E.
    Vet Parasitol; 2012 Dec 21; 190(3-4):333-9. PubMed ID: 22884910
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency.
    Takemura N, Toda N, Miyagawa Y, Asano K, Tejima K, Kanno N, Arisawa K, Kurita T, Nunokawa K, Hirakawa A, Tanaka S, Hirose H.
    J Vet Med Sci; 2009 Jul 21; 71(7):925-9. PubMed ID: 19652480
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy.
    Ferasin L, Kilkenny E, Ferasin H.
    J Vet Cardiol; 2020 Aug 21; 30():23-31. PubMed ID: 32645686
    [Abstract] [Full Text] [Related]

  • 26. Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds.
    Couto KM, Iazbik MC, Marín LM, Zaldivar-López S, Beal MJ, Gómez Ochoa P, Couto CG.
    Vet Clin Pathol; 2015 Sep 21; 44(3):405-9. PubMed ID: 25982692
    [Abstract] [Full Text] [Related]

  • 27. The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study.
    Borgarelli M, Ferasin L, Lamb K, Chiavegato D, Bussadori C, D'Agnolo G, Migliorini F, Poggi M, Santilli RA, Guillot E, Garelli-Paar C, Toschi Corneliani R, Farina F, Zani A, Dirven M, Smets P, Guglielmini C, Oliveira P, Di Marcello M, Porciello F, Crosara S, Ciaramella P, Piantedosi D, Smith S, Vannini S, Dall'Aglio E, Savarino P, Quintavalla C, Patteson M, Silva J, Locatelli C, Baron Toaldo M.
    J Vet Cardiol; 2021 Aug 21; 36():77-88. PubMed ID: 34118562
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone-a pilot study.
    Hezzell MJ, Boswood A, López-Alvarez J, Lötter N, Elliott J.
    J Vet Cardiol; 2017 Aug 21; 19(4):325-338. PubMed ID: 28734620
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease.
    Klein S, Nolte I, Granados-Soler JL, Lietz P, Sehn M, Raue JF, Rohn K, Packeiser EM, Bach JP.
    BMC Vet Res; 2022 Jul 02; 18(1):256. PubMed ID: 35780161
    [Abstract] [Full Text] [Related]

  • 31. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
    Fox PR, Oyama MA, Hezzell MJ, Rush JE, Nguyenba TP, DeFrancesco TC, Lehmkuhl LB, Kellihan HB, Bulmer B, Gordon SG, Cunningham SM, MacGregor J, Stepien RL, Lefbom B, Adin D, Lamb K.
    J Vet Intern Med; 2015 Jan 02; 29(1):171-9. PubMed ID: 25308881
    [Abstract] [Full Text] [Related]

  • 32. Plasma atrial natriuretic peptide is an early diagnosis and disease severity marker of myxomatous mitral valve disease in dogs.
    Ebisawa T, Ohta Y, Funayama M, Yamano S, Mizuno M, Mizuno T, Kasuya A, Sawada T, Lee J, Mizukoshi T, Uechi M.
    Res Vet Sci; 2013 Jun 02; 94(3):717-21. PubMed ID: 23312500
    [Abstract] [Full Text] [Related]

  • 33. [NT-proBNP as a diagnostic marker in dogs with dyspnea and in asymptomatic dogs with heart murmur].
    Haßdenteufel E, Kresken JG, Henrich E, Hildebrandt N, Schneider C, Stosic A, Schneider M.
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 Jun 02; 40(3):171-9. PubMed ID: 22688794
    [Abstract] [Full Text] [Related]

  • 34. Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease.
    Pelander L, Häggström J, Ley CJ, Ljungvall I.
    J Vet Intern Med; 2017 May 02; 31(3):805-813. PubMed ID: 28370332
    [Abstract] [Full Text] [Related]

  • 35. Can cartilage intermediate layer protein 1 (CILP1) use as a novel biomarker for canine myxomatous mitral valve degeneration levels or not?
    Kim HJ, Kim J, Kim S, Kim HJ.
    BMC Vet Res; 2023 Mar 07; 19(1):59. PubMed ID: 36882760
    [Abstract] [Full Text] [Related]

  • 36. Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.
    Zhou Q, Wu Z, Li L, Zhou H, Chen Y, Guo S, Guo Y, Ma X, Zhang J, Feng W, Cui X, Qiu C, Xu M, Deng G.
    J Proteomics; 2023 Jun 30; 282():104924. PubMed ID: 37146676
    [Abstract] [Full Text] [Related]

  • 37. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs.
    Oyama MA, Rush JE, Rozanski EA, Fox PR, Reynolds CA, Gordon SG, Bulmer BJ, Lefbom BK, Brown BA, Lehmkuhl LB, Prosek R, Lesser MB, Kraus MS, Bossbaly MJ, Rapoport GS, Boileau JS.
    J Am Vet Med Assoc; 2009 Dec 01; 235(11):1319-25. PubMed ID: 19951101
    [Abstract] [Full Text] [Related]

  • 38. Serial measurements of cardiac troponin I in heart failure secondary to canine mitral valve disease.
    Chan IP, Wu SY, Chang CC, Chen WY.
    Vet Rec; 2019 Sep 21; 185(11):343. PubMed ID: 31439824
    [Abstract] [Full Text] [Related]

  • 39. Plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with pulmonic stenosis.
    Kobayashi K, Hori Y, Chimura S.
    J Vet Med Sci; 2014 Jun 21; 76(6):827-31. PubMed ID: 24561377
    [Abstract] [Full Text] [Related]

  • 40. Biologic variability of N-terminal pro-brain natriuretic peptide in healthy dogs and dogs with myxomatous mitral valve disease.
    Winter RL, Saunders AB, Gordon SG, Buch JS, Miller MW.
    J Vet Cardiol; 2017 Apr 21; 19(2):124-131. PubMed ID: 28111138
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.